PR Newswire
VADUZ, Liechtenstein, Feb. 18, 2026
VADUZ, Liechtenstein, Feb. 18, 2026 /PRNewswire/ — Implantica AG (publ) invites investors to a presentation of the Year-end Report (Q5 2025) at 15:00 CET on February 25. The Year-end Report (Q4 2025) will be published at 8:00 a.m. CET on the same day.
The presentation will be in English via webcast with teleconference:
If you wish to participate via webcast, please use the following link:
- https://implantica.events.inderes.com/q4-report-2025
If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference.
- https://events.inderes.com/implantica/q4-report-2025/dial-in
Speakers:
- CEO Peter Forsell
- CFO Andreas Öhrnberg
- Chief Corporate Affairs Officer Nicole Pehrsson
For further information, please contact:
Nicole Pehrsson, Investor RelationsTelephone (CH): +41 43 505 20 [email protected]
Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.
The company’s Certified Adviser is FNCA Sweden AB, [email protected]
The information was sent for publication, through the agency of the contact person set out above, on February 18, 2026 at 12:45 p.m. CET.
About Implantica
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/implantica/r/implantica-presents-the-year-end-report–q4-2025–on-february-25-at-15-00-cet,c4309449
The following files are available for download:
https://mb.cision.com/Main/19732/4309449/3940545.pdf Implantica presents the Year-end Report (Q4 2025) on February 25
at 15:00 CET
View original content:https://www.prnewswire.co.uk/news-releases/implantica-presents-the-year-end-report-q4-2025-on-february-25-at-1500-cet-302691499.html
Comparto con muchos la visión de que la universidad, salgo contadas excepciones va muy por detrás del mundo real, con una actitud muy reactiva.
Hace años que salà de ella, aunque continúo ligado, intentando terminar otros estudios que hace tiempo comence (soy un ferviente entusiasta de estar continuamente formándome… aunque solamente sea como intención, y el estar matriculado en alguna asignatura de una 2ª carrera me ayuda en ocasiones a autoexigirme un plus adicional).
Lo penoso es que solamente mantengo relación, muy de vez en cuando, con 2 profesores. Los únicos de los que guardo un buen recuerdo. Y casualidad esta que no son profesionales de la docencia, sino profesionales de la industria privada que están en la docencia por convicción e ilusión personal. Cuánto tiene que aprender la universidad de muchas escuelas de negocios…